Tumor hypoxia is associated with several features of aggressive glioma growth, including migration, invasion, and stemness. Most of the cellular adaptation to hypoxia is mediated by the hypoxia-inducible factors HIF-1α and HIF-2α, but regulation of these factors by both oxygen-dependent and -independent mechanisms in brain tumors is only partially understood. Here, we show that the p75 neurotrophin receptor (p75 NTR ) is stabilized at hypoxia in murine glioma in vivo, as well as in primary human glioma cultures in vitro. Expression of p75 NTR resulted in increased stabilization of HIF-1α and HIF-2α, and RNAi or pharmacologic targeting of p75 NTR diminished HIF stabilization and HIF-dependent signaling at hypoxia. Consequentially, p75 NTR inhibition resulted in decreased migration, invasion, and stemness in response to hypoxia, suggesting that p75 NTR is a central regulator of hypoxia-induced glioma aggressiveness. Together, our findings support the literature that identifies p75 NTR as a potential therapeutic target in brain tumors.
Introduction
Gliomas are the most common primary malignant brain tumors. Despite a deeper molecular understanding of the disease, survival rates have not changed dramatically in the past several decades, and highgrade glioma remains one of the most lethal cancers. Both genotypic and phenotypic intratumoral heterogeneity have been proposed as key factors underlying the lack of long-term therapeutic response to aggressive treatment. Specifically, tumor cells with stem cell characteristics have been suggested to underlie therapeutic resistance and tumor recurrence in high-grade glioma. Intriguingly, the maintenance of stem cell phenotypes appears to be regulated by the tumor microenvironment in addition to specific genetic aberrations. Glioma cells with stem cell characteristics appear to be restricted primarily to specific tumor niches, most frequently in perinecrotic (hypoxic) and/or perivascular tumor areas. It is likely that these localizations are not random: microenvironmental cues unique to the perivascular microenvironment have been demonstrated to enhance glioma stem cell characteristics [1, 2] , and hypoxia-inducible factors (HIF-1α and HIF-2α) elevated in perinecrotic tumor areas are central transcriptional regulators of the stem cell phenotype [3, 4] . p75 neurotrophin receptor (p75 NTR or CD271), a member of the tumor necrosis factor receptor superfamily, has been implicated in several steps of glioma tumorgenesis [5] . p75 NTR mediates glioma invasion and progression through γ-secretase-dependent and -independent mechanisms [6, 7] , and its expression has been linked to stemness both in glioma and other cancers such as melanoma, breast cancer, esophageal squamous cell carcinomas, and hypopharyngeal carcinoma [8] [9] [10] [11] [12] . The expression of p75 NTR with regards to intratumoral heterogeneity and the possible regulation of p75 NTR by microenvironmental factors, are largely unknown in the context of brain tumors. However, both γ-secretase-mediated cleavage of p75 NTR to generate a p75 intracellular domain (p75-ICD) as well as expression of p75 NTR itself has been shown to be induced by hypoxia in other cellular contexts [13] . Here, we investigate the expression and regulation of p75 NTR in perinecrotic tumor areas and hypoxic glioma cells. We found that p75 NTR expression is restricted primarily to perinecrotic, hypoxic tumor areas, and that p75 NTR protein levels are upregulated at hypoxia in primary human glioma cells. The p75 NTR itself regulated HIF protein levels, and was required for hypoxia-induced stemness, migration, and invasion in glioma. Our data highlight the interplay between p75
2. Material and methods
Reagents
The following regents were used in this study: EGF, basic FGF (bFGF) (PeproTech, NJ); N2, B27, DMEM, DMEM/F12 (Life Technology); Accutase (Thermo Fisher Scientific) Polyornithine (Sigma-Aldrich, St. Louis, MO); Laminin-521 (Biolamina, Sweden); Xtreme gene 9 (Roche); HiPerFect (Qiagen); Ro 08-2750 (p75 NTR antagonist) (Santa Cruz, Dallas, TX). Small interfering RNAs: non-targeting (D-001810-01-20), HIF1A (LQ-004018-00-0002,), EPAS1 (LQ-004814-00-0002), NGFR (J-009340-08-0002) from GE Dharmacon. Plasmids: RFP-empty vector, RFP-p75 full length vector were kind gifts from Prof. Chao's Lab; all plasmids were verified by sequencing. Antibodies: NGFR (SC-13577, Santa Cruz; p75 antibody kindly provided by prof. M. Chao); HIF-1α (NB100-479, Novus Biologicals, Littleton, CO); HIF-2α (ab199, Abcam, Cambridge, MA); SDHA (ab14715, Abcam).
Generation of murine glioma
Generation of PDGF-induced murine gliomas using RCAS/tv-a has been previously described [15] . DF-1 cells (10 5 cells in 1 μL PBS)
transfected with RCAS-PDGFB [16] were injected into the left hemisphere of the cerebral cortex of neonatal Ntv-a Ink4a/Arf -/-mice from an entry point of the skull using a 10-μL gas-tight Hamilton syringe. Mice were monitored daily and euthanized upon appearance of symptoms of glioma. All animal procedures were approved by the Malmö-Lund Ethical Committee (Dnr. M186-14) and the use of laboratory animals was conducted in accordance with European Union directive on the subject of animal rights.
Immunofluorescent labelling of tumor cryosections
Tumor tissue from mouse brains was embedded in OCT and snapfrozen in pre-cooled isopentane. The frozen material was stored at −80°C until sectioning. Tumor tissue was cut into 5 µm sections and placed on glass slides. Sections were dried at room temperature for 30 min and fixed in pre-cooled acetone. After permeabilization in 0.3% Triton X -100 Expression levels (full-length) were quantified and relative expression is plotted in bar graphs, normalized to average normal brain expression levels. B. Immunofluorescent staining of perinecrotic areas in PDGFB-induced murine glioma for p75 NTR (green) and DAPI (blue). Scale bars represent 50 µm. C-D.
Immunofluorescent staining of PDGFB-induced murine glioma for p75 NTR (green), HIF-1α (red) or HIF-2α (red), and DAPI (blue) in perinecrotic areas. Scale bars represent 50 µm. E. p75 NTR protein expression in different glioma cell lines analyzed by western blot. Cells (U251, U3065, U3020, U3082, and U3084) were grown at 21% or 1% oxygen condition for 24 h. Data represent three independent experiments and are expressed as means ± SEM, n = 3. * * P < 0.01.
(Sigma) PBS for 5 min, sections were blocked in serum-free protein block (DAKO, Glostrup, Denmark) for 30 min and incubated respectively with the indicated antibodies (p75, HIF-1α, and HIF-2α) overnight at 4°C. After washing with PBS, sections were incubated with Alexa Fluorchrome 488 and 546 followed by washing and mounting in Vechtashield Hard Set with DAPI (Vector laboratories, Burlingame, CA). Images were acquired using Olympus BX63 microscope and DP80 camera and cellSens Dimension v1.12 software (Olympus Corporation).
(caption on next page) 
Cell culture and treatment
U251MG cells and DF-1 chicken fibroblast cells were obtained from ATCC, grown in DMEM supplemented with 10% FBS and 1% PenStrep solution and dissociated using Trypsin. Primary glioma cells were obtained from HGCC (hgcc.se) and cultured in DMEM/F12 with Glutamax supplemented with 1% PenStrep, N2, B27, EGF, and FGF as previously described [17] . Cells were grown to subconfluence, dissociated by accutase and grown either as neurospheres or monolayer on polyornithine and laminin coated plastic. Hypoxia was generated by using a Whitley H35 hypoxia station (Don Whitley Scientific). Cells were treated with Ro 08-2750 (50 nM) for 24 h or 72 h. Plasmids were transfected using Xtreme gene 9 and siRNAs using HiPerFect according to manufacturer's instructions.
Quantitative real-time PCR (qPCR)
Total RNA of cultured cells was isolated with Rneasy Mini Kit together with the Qiashredder Kit (Qiagen) according to the manufacturers' instructions. cDNAs was synthesized using MultiScribe Reverse Transcriptase enzyme (Applied Biosystems). The amplifications were run using QuantStudio 7 Real-Time PCR system with SYBR Green Master Mix (Applied Biosystems). Relative gene expression was normalized to the expression of three housekeeping genes (UBC, SDHA and YWHAZ) using comparative Ct method [28] . All the amplifications were performed in triplicate using primers as follows:
Western blot
Cell lysates were prepared in RIPA buffer supplemented with complete protease inhibitor (Roche) on ice. Protein concentrations were determined using the Bradford method. Equal amounts of protein lysates (around 50-80 µg) were loaded on 4-15% Mini-PROTEAN® TGX™ Precast Protein Gels and transferred onto trans-blot turbo mini PVDF transfer packs (Bio-Rad, Hercules, CA). Subsequently, the membranes were blocked with 5% skim milk for 1 h at room temperature and then treated with the appropriate antibody at 4°C overnight. Protein expression was visualized with an Amersham Imager 600 Western blot system. SDHA was used as a loading control. ImageJ software was used to analyze the Western blot images.
Luciferase assays
For the luciferase reporter assay, cells were co-transfected with HRE-luc (gift from Navdeep Chandel, Addgene #26731) and pCMVrenilla (Promega, Madison, WI) and then analyzed for luciferase using the Dual-Luciferase Reporter Assay System (Promega) on a Synergy 2 plate reader (BioTek) [29] .
Side population assay
U3065 cells from indicated groups were resuspended at 1 × 10 6 cells/mL and incubated at 37°C, 30 min with or without Fumitremorgin C (FTC) (Sigma). Cells were incubated for another 90 min with 5 mg/ mL Hoechst 33342 with periodic shaking and then analyzed on a FACSVerse instrument (BD) equipped with a 405 nm violet laser. Dual wavelength detection was performed using 448/45 (Hoechst 33342-blue) and 613/18 (Hoechst 33342-red) filters. Data were analyzed using FlowJo software.
Sphere formation
U3065 cells were plated at single cell density in 100 μL drops of a 98 well round bottom plate and grown for one week with indicated treatments. Pictures were acquired with Zeiss microscope and sphere areas were measured using ImageJ and presented as relative area to control.
Fig. 2. p75
NTR contributes to HIF-1α and HIF-2α stabilization at hypoxia. Quantifications of western blot and qPCR data are from at least three independent experiments, and were expressed as means ± SEM, n = 3. * P < 0.05, * * P < 0.01.
Gene
Forward primer Reverse primer parallel wound was created in the center of each well by scratching with a sterile P200 pipette tip. Cells were grown at hypoxia after removing the debris. The wound areas were estimated using a light microscope (ZESS) equipped with a digital camera, and two measurements of wound area were made at randomly chosen points in each well. The extent of wound closure was presented as the percentage by which the original scratch area had decreased at each measured time point. Transwell migration assays were performed in 24-well transwell plates. After treatment at different intervals, an aliquot of cells (1 × 10 6 cells/mL, 0.1 mL/well) was plated into the upper chamber of the transwell, followed by resuspension in DMEM/F12 medium (without growth factors). The lower chamber was filled with DMEM/F12 medium (with growth factors) as a chemoattractant. After being incubated at 37°C for 72 h, the non-migrating cells on the upper surface of the membranes were removed by cotton swab, and the cells that migrated on the bottom face of the membranes were stained by crystal violet and counted using a microscope.
Statistical analysis
Data are presented as the means ± SEM from at least three independent experiments. Comparisons between multiple groups were performed using one-way analysis of variance and Dunnett's test. Three levels of significance were used: * , P < 0.05, * *, P < 0.01, * ** , P < 0.001.
Results

p75 NTR expression is induced at hypoxia in glioma in vivo and in vitro
We generated high-grade gliomas in mice by forcing expression of PDGFB in Nestin-expressing cells of the neonatal brain of Nestin/tv-a Ink4a/Arf -/-mice using the RCAS/tv-a system, as previously described [15, 16] . Protein levels of full-length and cleaved (carboxyterminal fragment; CTF) p75 NTR were higher in tumors as compared to the normal brains of non-tumor bearing mice (Fig. 1A) . The relative increase in p75-CTF in tumors is consistent with generally higher ADAM expression and activity in tumor tissue [30] . Staining PDGFB-induced gliomas for p75 NTR expression revealed that the expression was low or undetectable in the majority of tumor cells, but high specifically in perinecrotic tumor areas (Fig. 1B) . Co-staining for HIF-1α and HIF-2α -markers of hypoxic tumor regions and thereby of the perinecrotic areas -confirmed that p75 NTR expression was confined to hypoxic areas ( Fig. 1C-D) . To test whether p75 NTR expression itself was regulated by hypoxia, we subjected a series of primary high-grade glioma cell cultures [17] , maintained under serum-free stem cell promoting conditions to growth under normoxic (21% O 2 ) or hypoxic (1% O 2 ) conditions. While expression of p75 NTR was low in the classical U251MG glioma cell line at all conditions tested as compared to other cell lines, primary glioma cells displayed dramatically increased p75 NTR protein levels at hypoxia (Fig. 1E) . Levels of the p75 intracellular domain (p75-ICD) were increased similarly to full-length levels, while p75-CTF levels were stable (Suppl. Fig. 1 ).
p75 NTR regulates HIF expression at hypoxia
To test the relationship between p75 NTR and HIFs at hypoxia, we used siRNA to knock down NGFR (encoding p75 NTR ), HIF1A (encoding HIF-1α), and EPAS1 (encoding HIF-2α), in U3065MG and U251MG cells. In both cell lines, knockdown of p75 NTR reduced the expression of both HIF-1α and HIF-2α at hypoxia, while knockdown of either HIF-1α or HIF-2α didn't show any effect on p75 NTR levels ( Fig. 2A-B) , suggesting that p75 NTR is an upstream regulator of hypoxia signaling and HIF expression. Conversely, forced expression of full-length p75 NTR in U251MG cells increased expression of both HIF-1α and HIF-2α at hypoxia (Fig. 2 C) . Similarly, activation of a hypoxia-responsive element (HRE)-luciferase construct was significantly enhanced in glioma cells overexpressing p75 NTR (Fig. 2D) . To test whether HIF downstream target genes were affected by p75 NTR , we either knocked down NGFR by siRNA, or inhibited p75 NTR using the specific inhibitor Ro 08-2750, in cells cultured at normoxia and hypoxia. Knockdown by siRNA was confirmed at the protein levels (Fig. 2E) , and resulted in decreased hypoxic induction of most classical HIF target genes tested (Fig. 2 F) . The specific p75 NTR inhibitor was used at a concentration (50 nM) that didn´t affect cell proliferation (Fig. 2 G) , and similarly decreased hypoxic induction of several HIF target genes (Fig. 2 H) . Taken together, these data show that expression of p75 NTR is enhanced by hypoxia, and that p75 NTR itself contributes to the stabilization and increased activity of HIFs.
Hypoxia-induced glioma stemness is dependent on p75 NTR
Hypoxia is associated with several traits of aggressive glioma cells, including stemness, migration, and invasion. To test the contribution of p75 NTR to these phenotypes, we first subjected primary glioma cells to the drug efflux-based side population (SP) assay [18] . As previously reported, culture under hypoxic conditions induced the SP of glioma cells (Fig. 3 A) . Targeting p75 NTR using siRNA significantly decreased the hypoxic induction of the SP fraction (Fig. 3 A) . Similarly, p75 NTR knockdown decreased hypoxic mRNA levels of stem cell markers NANOG, SOX2, ID1, and OCT4 (Fig. 3B) . Finally, p75 NTR knockdown decreased the size of spheres formed during the sphere forming assay both at normoxia and hypoxia (Fig. 3 C) . Ro 08-2750 treatment had similar effect (with small variations) as siRNA knockdown (Fig. 3D-F) , with the exception of the SP assay, where Ro 08-2750 failed to affect the SP fraction of glioma cells (Fig. 3D) .
Hypoxia-induced glioma migration is dependent on p75 NTR
We next tested the effect of p75 NTR knockdown or Ro 08-2750 treatment on migration at hypoxia. As expected, hypoxic conditions enhanced migration of glioma cells, as measured by the wound healing/ scratch assay (Fig. 4A-B) . While p75 NTR siRNA or Ro 08-2750 treatment did not significantly affect proliferation of glioma cells, both entirely diminished the enhanced migration of hypoxic cells (Fig. 4A-B) . Similarly, the transwell migration assay revealed that hypoxia induced migration of glioma cells (Fig. 4C-D) . Again, knockdown of p75 NTR or treatment with Ro 08-2750 diminished the effect of hypoxia (Fig. 4C-D) . Together, our data demonstrate that p75 NTR is required for several hypoxia-induced phenotypes in glioma. 
Discussion
In this study, we discovered that the potential therapeutic target p75 NTR regulates HIF signaling and glioma cell stemness in response to hypoxia. In vivo, we demonstrated increased p75 NTR expression in mouse glioma samples, specifically enriched in hypoxic perinecrotic tumor areas. Forced expression of p75 NTR resulted in increased HIF protein levels at hypoxia both in vitro and in vivo.
While regulation of HIF-1α and HIF-2α by p75 NTR has been previously reported in other cellular contexts [13] , less is known about the dramatic induction of p75 NTR protein levels at hypoxia, as reported here. RNAi-mediated knockdown of either HIF-1α or HIF-2α did not significantly affect p75 NTR levels at hypoxia, suggesting that the hypoxic induction of p75 NTR was not HIF-dependent, and that p75 NTR is not a classical HIF downstream target gene. In agreement with these findings, NGFR mRNA levels were not induced by hypoxia in the majority of primary glioma cultures tested (data not shown). It is noteworthy that the induction of p75 NTR protein levels at hypoxia was most clear when using primary cultures of human glioma, while the classical U251MG cell line displayed generally lower p75 levels at both normoxia and hypoxia. The hypoxic induction seen in primary human glioma cell cultures in vitro was supported by the finding that p75 NTR levels were restricted to perinecrotic, hypoxic, tumor areas in murine gliomas in vivo. These findings together further show that primary glioma cultures may more accurately represent glioma biology in vivo.
A growing literature has implicated HIFs as central regulators of stemness both in glioma and other tumor types [19] [20] [21] [22] [23] [24] . While it appears that stem-like tumor cells frequently have an amplified response to hypoxia as compared to non-stem tumor bulk, the mechanisms underlying this discrepancy remain poorly understood. We have previously demonstrated that one marker of stem-like glioma cells -CD44 -can actively contribute to HIF stabilization in hypoxic and pseudohypoxic glioma cells [14, 25] . While p75 NTR may be controversial as a stem cell marker in glioma, its expression has been linked to stem-like tumor cells in several other malignanices [8, [10] [11] [12] . Our data thus add p75 NTR to the growing list of potential cell surface stem cell markers that can actively contribute to the stem cell state, rather than simply being correlated markers of stemness. Expression of p75 NTR has been linked to several aspects of aggressive glioma growth, including migration and invasion, by various Lower panel shows quantification of relative sphere area. Scale bars represent 100 µm. Data are from at least three independent experiments, and were expressed as means ± SEM, n = 3. * P < 0.05, * * P < 0.01, * ** P < 0.001. mechanisms in a large number of elegant studies [6, 7, 26, 27] . Our study adds to this literature by demonstrating specific roles in hypoxic tumor cells and regulation of the phenotypic cellular adaptation to oxygen shortage. These studies together support the development of therapeutic strategies to target p75 NTR and its signaling in glioma, and there are several conceivable strategies that may be employed to this end. Like many other cell surface markers associated with aggressive brain tumor growth like Notch and CD44, p75 NTR is a substrate of γ-secreatase and may be sensitive to γ-secretase inhibitors. In our study, we complemented RNAi targeting of p75 NTR with the use of the Ro 08-2750 inhibitor of p75 NTR -ligand interactions. This inhibitor was effective in diminishing hypoxia-induced stemness dependent on p75 NTR in our in vitro setting, and should be evaluated further for in vivo use.
Conclusions
Taken together, our findings highlight p75 NTR as a regulator of the hypoxic response of glioma cells, and a sustainer of glioma stemness. Targeting p75 NTR may offer a new therapeutic strategy against aggressive brain tumors.
